Home

James Mulay

CIK 1684531 · last filed 2026-07-14

James Mulay is a corporate insider who has filed 23 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing, for CGON, was dated Jul 14, 2026. Across all open-market trades the lifetime net is −$6.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $222.0K across reported positions. 5 SEC filings were submitted jointly with Fulgent Genetics, Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$222.0K

Companies

2

Total Filings

23

Lifetime Open-Market Net

-$6.28M

Filer Profile

Reported Address
C/O CG ONCOLOGY, INC.
400 SPECTRUM CENTER DRIVE, SUITE 2040
IRVINE, CA 92618
Related Filers
Fulgent Genetics, Inc. — 5 joint filings, latest 2019-06-03
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CGON Director 0 $67.15 $0 -$6.28M 12 2026-07-14
FLGT Director 10,000 $22.20 $222.0K $0 4 2019-06-03

Recent Filings

23 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-14 CGON Mixed — -$1.17M EDGAR
2026-07-10 CGON Notice (144) −20,237 -$1.48M EDGAR
2026-07-01 CGON Notice (144) −3,928 -$279.1K EDGAR
2026-06-16 CGON Mixed — -$99.1K EDGAR
2026-06-05 CGON Grant (A) — $0 EDGAR
2026-04-20 CGON Mixed — -$567.5K EDGAR
2026-04-17 CGON Notice (144) −17,564 -$1.17M EDGAR
2026-03-17 CGON Mixed — -$105.8K EDGAR
2026-01-13 CGON Mixed — -$450.3K EDGAR
2026-01-09 CGON Notice (144) −13,109 -$549.7K EDGAR
Showing 1–10 of 23
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.